{"id":73937,"date":"2026-06-15T21:29:18","date_gmt":"2026-06-15T21:29:18","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=73937"},"modified":"2026-06-15T21:34:45","modified_gmt":"2026-06-15T21:34:45","slug":"american-analyst-updates-june-15th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/","title":{"rendered":"American Analyst Updates: June 15th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

Today\u2019s analyst ratings show a mixed but still broadly constructive market tone, with increasing dispersion in conviction.\u00a0 Analysts continue to support long-term growth themes in areas like semiconductors, AI infrastructure, biotech, and high-quality industrials, where price targets are being meaningfully raised (in some cases aggressively).<\/p>\n

At the same time, there is a noticeable increase in downgrades,especially in cyclicals, consumer exposure, and certain software names. These moves generally reflect valuation sensitivity, slowing growth normalization, or reduced near-term catalysts rather than outright deterioration in fundamentals.<\/p>\n

The key takeaway is that analysts are not uniformly bearish or bullish, instead they are becoming more selective and rewarding companies with clear earnings momentum and penalizing those where expectations appear ahead of fundamentals. This typically indicates a late-cycle or re-pricing environment where stock-specific execution matters more than broad sector exposure.<\/p>\n

131 Analyst Updates<\/strong><\/h3>\n

3M (MMM) \u2014 Goldman Sachs upgraded 3M and reiterated a Buy rating with a $190 price target.<\/p>\n

Absci (ABSI) \u2014 Guggenheim raised its price target to $15.00 from $10.00 and maintained a Buy rating.<\/p>\n

Acadia Realty Trust (AKR) \u2014 KeyCorp reiterated its Sector Weight rating.<\/p>\n

Accenture (ACN) \u2014 Jefferies Financial Group lowered its price target to $185.00 from $210.00 and maintained a Hold rating.<\/p>\n

Accenture (ACN) \u2014 Morgan Stanley downgraded Accenture to Equal Weight from Overweight and lowered its price target to $177.00 from $240.00.<\/p>\n

Acerinox (ANIOY) \u2014 Morgan Stanley reiterated its Overweight rating on Acerinox.<\/p>\n

Adecoagro (AGRO) \u2014 JPMorgan Chase & Co. raised its price target to $10.50 from $7.00 and maintained an Underweight rating.<\/p>\n

Advanced Micro Devices (AMD) \u2014 Wolfe Research initiated coverage with an Outperform rating and a $450.00 price target.<\/p>\n

American Homes 4 Rent (AMH) \u2014 BMO Capital Markets raised its price target to $39.00 from $36.00 and maintained a Market Perform rating.<\/p>\n

AMETEK (AME) \u2014 Citigroup initiated coverage of AMETEK with a Neutral rating and a $257.00 price target.<\/p>\n

Andersons (ANDE) \u2014 Benchmark reiterated its Buy rating on Andersons.<\/p>\n

AON (AON) \u2014 Piper Sandler lowered its price target to $355.00 from $360.00 and maintained an Overweight rating.<\/p>\n

ArcBest (ARCB) \u2014 Citigroup raised its price target to $202.00 from $150.00 and maintained a Buy rating.<\/p>\n

Archer Daniels Midland (ADM) \u2014 UBS raised its price target to $95.00 from $90.00 and maintained a Buy rating.<\/p>\n

ASML (ASML) \u2014 Sanford C. Bernstein reiterated its Buy rating on ASML.<\/p>\n

Assa Abloy (ASAZY) \u2014 Barclays reiterated its Overweight rating on Assa Abloy.<\/p>\n

Assembly Biosciences (ASMB) \u2014 Mizuho raised its price target to $45.00 from $40.00 and maintained an Outperform rating.<\/p>\n

Autoliv (ALV) \u2014 UBS raised its price target to $122.00 from $110.00 and maintained a Neutral rating.<\/p>\n

Aviat Networks (AVNW) \u2014 Citigroup upgraded Aviat Networks to an Outperform rating.<\/p>\n

Aviat Networks (AVNW) \u2014 Northland Securities upgraded Aviat Networks to Outperform from Market Perform and raised its price target to $25.00 from $20.00.<\/p>\n

Avista (AVA) \u2014 Barclays lowered its price target to $39.00 from $42.00 and maintained an Equal Weight rating.<\/p>\n

Axon Enterprise (AXON) \u2014 Piper Sandler reiterated its Overweight rating and set a $674.00 price target.<\/p>\n

Baldwin Insurance Group (BWIN) \u2014 TD Cowen reiterated its Buy rating on Baldwin Insurance Group.<\/p>\n

Belite Bio (BLTE) \u2014 HC Wainwright reiterated its Buy rating and maintained a $200.00 price target.<\/p>\n

Better Home & Finance (BETR) \u2014 Roth MKM initiated coverage of Better Home & Finance with a Buy rating and a $35.00 price target.<\/p>\n

Biodesix (BDSX) \u2014 HC Wainwright initiated coverage of Biodesix with a Buy rating and a $26.00 price target.<\/p>\n

Biogen (BIIB) \u2014 Mizuho lowered its price target to $221.00 from $236.00 and maintained an Outperform rating.<\/p>\n

Braemar Hotels & Resorts (BHR) \u2014 Robert W. Baird lowered its price target to $2.00 from $3.50 and maintained a Neutral rating.<\/p>\n

Braiin (BRAI) \u2014 Maxim Group initiated coverage of Braiin with a Buy rating and a $10.00 price target.<\/p>\n

BrainsWay (BWAY) \u2014 HC Wainwright reiterated its Buy rating and maintained a $17.00 price target.<\/p>\n

Braze (BRZE) \u2014 TD Cowen reiterated its Buy rating on Braze.<\/p>\n

Brixmor Property Group (BRX) \u2014 BMO Capital Markets raised its price target to $37.00 from $35.00 and maintained an Outperform rating.<\/p>\n

Brookdale Senior Living (BKD) \u2014 Compass Point initiated coverage of Brookdale Senior Living with a Buy rating and a $22.00 price target.<\/p>\n

C.H. Robinson Worldwide (CHRW) \u2014 Citigroup downgraded C.H. Robinson Worldwide to Neutral from Buy and set a $199.00 price target.<\/p>\n

CACI International (CACI) \u2014 JPMorgan lowered its price target to $645.00 from $700.00 and maintained an Overweight rating.<\/p>\n

Caesars Entertainment (CZR) \u2014 Stifel downgraded Caesars Entertainment to Hold from Buy and set a $31.00 price target.<\/p>\n

Calian Group (CGY) \u2014 Ventum raised its price target to C$100.00 from C$94.00 and maintained a Buy rating.<\/p>\n

Cameco (CCJ) \u2014 Sanford C. Bernstein reiterated its Outperform rating and maintained a $135.00 price target.<\/p>\n

Canadian Pacific Kansas City (CP) \u2014 BMO Capital Markets raised its price target to C$142.00 from C$132.00 and maintained an Outperform rating.<\/p>\n

Canadian Solar (CSIQ) \u2014 Mizuho raised its price target to $18.00 from $15.00 and maintained a Neutral rating.<\/p>\n

Capstone Copper (CS) \u2014 Scotiabank raised its price target to C$18.00 from C$15.50 and maintained a Sector Outperform rating.<\/p>\n

Cardinal Infrastructure Group (CDNL) \u2014 Oppenheimer raised its price target to $80.00 from $60.00 and maintained an Outperform rating.<\/p>\n

CareTrust REIT (CTRE) \u2014 BMO Capital Markets raised its price target to $47.00 from $46.00 and maintained an Outperform rating.<\/p>\n

Casey’s General Stores (CASY) \u2014 Deutsche Bank reiterated its Buy rating and maintained a $1,000.00 price target.<\/p>\n

Celldex Therapeutics (CLDX) \u2014 HC Wainwright reiterated its Buy rating and maintained a $42.00 price target.<\/p>\n

Ceva (CEVA) \u2014 Needham initiated coverage with a Buy rating and a $55.00 price target.<\/p>\n

CF Industries (CF) \u2014 BNP Paribas Exane lowered its price target to $120.00 from $140.00 and maintained a Neutral rating.<\/p>\n

Champion Iron (CIA) \u2014 Scotiabank lowered its price target to C$5.50 from C$6.00 and maintained a Sector Outperform rating.<\/p>\n

Cheesecake Factory (CAKE) \u2014 Citigroup downgraded Cheesecake Factory to Neutral from Buy.<\/p>\n

Cheesecake Factory (CAKE) \u2014 Northcoast Research downgraded Cheesecake Factory to Neutral from Buy.<\/p>\n

Chugai Pharmaceutical (CHGCY) \u2014 Goldman Sachs upgraded Chugai Pharmaceutical to a Buy rating.<\/p>\n

Cintas (CTAS) \u2014 Truist Financial lowered its price target to $225.00 from $255.00 and maintained a Buy rating.<\/p>\n

Citizens Financial Group (CFG) \u2014 Stephens initiated coverage with an Equal Weight rating.<\/p>\n

Citizens Holding (CIZN) \u2014 UBS set a $30.00 price target on Citizens Holding.<\/p>\n

Cloudflare (NET) \u2014 Citi, New Street, and Citizens JMP all reiterated Market Outperform ratings, with JMP setting a $270 target.<\/p>\n

CME Group (CME) \u2014 Piper Sandler reiterated its Overweight rating and maintained a $329.00 price target.<\/p>\n

CME Group (CME) \u2014 UBS reiterated its Overweight rating on CME Group.<\/p>\n

Columbus McKinnon (CMCO) \u2014 DA Davidson lowered its price target to $17.00 from $20.00 and maintained a Neutral rating.<\/p>\n

Corporacion America Airports (CAAP) \u2014 JPMorgan raised its price target to $33.00 from $30.00 and maintained an Overweight rating.<\/p>\n

Coupang (CPNG) \u2014 CLSA initiated coverage with an Outperform rating and a $24.00 price target.<\/p>\n

Cracker Barrel Old Country Store (CBRL) \u2014 BofA raised its price target to $40.00 from $34.00.<\/p>\n

Credicorp (BAP) \u2014 JPMorgan downgraded Credicorp to Neutral from Overweight and set a $415.00 price target.<\/p>\n

Crinetics Pharmaceuticals (CRNX) \u2014 HC Wainwright reiterated its Buy rating and maintained a $81.00 price target.<\/p>\n

Crocs (CROX) \u2014 Stifel raised its price target to $125.00 from $105.00 and maintained a Hold rating.<\/p>\n

CSX (CSX) \u2014 Royal Bank of Canada reiterated its Outperform rating on CSX.<\/p>\n

Curbline Properties (CURB) \u2014 Wolfe Research downgraded Curbline Properties to Peer Perform from Outperform.<\/p>\n

D-Wave Quantum (QBTS) \u2014 Mizuho raised its price target to $35 from $29 and maintained an Outperform rating.<\/p>\n

Darden Restaurants (DRI) \u2014 Citigroup raised its price target to $245.00 from $238.00 and maintained a Buy rating.<\/p>\n

Datadog (DDOG) \u2014 Citigroup downgraded Datadog to Neutral from Outperform.<\/p>\n

Datadog (DDOG) \u2014 Craig-Hallum initiated coverage with a Buy rating.<\/p>\n

Datadog (DDOG) \u2014 Jefferies upgraded Datadog to a Buy rating.<\/p>\n

Datadog (DDOG) \u2014 KeyCorp upgraded Datadog to an Overweight rating.<\/p>\n

Datadog (DDOG) \u2014 Morgan Stanley upgraded Datadog to an Overweight rating.<\/p>\n

Datadog (DDOG) \u2014 Needham initiated coverage with a Buy rating.<\/p>\n

Datadog (DDOG) \u2014 Truist Financial upgraded Datadog to Buy from Hold and raised its price target to $300.00 from $190.00.<\/p>\n

Datadog (DDOG) \u2014 Wedbush changed its rating on Datadog to Neutral from Outperform.<\/p>\n

Devon Energy (DVN) \u2014 Raymond James lowered its price target to $66.00 from $72.00 and maintained a Strong Buy rating.<\/p>\n

DexCom (DXCM) \u2014 Piper Sandler reiterated its Overweight rating and raised its price target to $88.00 from $75.00.<\/p>\n

Dolby Laboratories (DLB) \u2014 Barrington Research reiterated its Outperform rating and maintained a $90.00 price target.<\/p>\n

DTE Energy (DTE) \u2014 Wells Fargo reiterated its Overweight rating and maintained a $165.00 price target.<\/p>\n

Duos Technologies Group (DUOT) \u2014 Ascendiant Capital Markets raised its price target to $22.00 from $17.00 and maintained a Buy rating.<\/p>\n

DuPont de Nemours (DD) \u2014 Goldman Sachs initiated coverage with a Neutral rating and a $53.00 price target.<\/p>\n

EchoStar (SATS) \u2014 New Street Research set a price target of $165 on EchoStar.<\/p>\n

Eli Lilly (LLY) \u2014 BMO reiterated an Outperform rating on Eli Lilly.<\/p>\n

Elicio Therapeutics (ELTX) \u2014 HC Wainwright raised its price target to $23 from $17 and maintained a Buy rating, while Rodman & Renshaw also reiterated a Buy rating.<\/p>\n

EPAM Systems (EPAM) \u2014 Wedbush initiated coverage with a Neutral (Sector Perform) rating and a $99 price target.<\/p>\n

Ero Copper (ERO) \u2014 Scotiabank reiterated an Outperform rating and raised its price target to C$55 from C$50.<\/p>\n

ESCO Technologies (ESE) \u2014 JPMorgan initiated coverage with an Overweight rating and a $420 price target.<\/p>\n

Exodus Movement (EXOD) \u2014 Cantor Fitzgerald reiterated an Overweight rating on Exodus Movement.<\/p>\n

Extreme Networks (EXTR) \u2014 Lake Street Capital raised its price target to $34 from $25 and maintained a Buy rating.<\/p>\n

ExxonMobil (XOM) \u2014 TD Cowen reiterated a Buy rating on ExxonMobil.<\/p>\n

Ferrari (RACE) \u2014 Morgan Stanley upgraded Ferrari to Overweight from Equal Weight and raised its price target to $438 from $388.<\/p>\n

Fifth Third Bancorp (FITB) \u2014 Stephens initiated coverage with an Equal Weight rating and a $58 price target.<\/p>\n

Firefly Aerospace (FLY) \u2014 KeyCorp upgraded Firefly Aerospace to Overweight from Sector Weight and set a $50 price target.<\/p>\n

Fox Corporation (FOXA) \u2014 UBS reiterated a Neutral rating, while Barclays lowered its price target to $60 from $67 and maintained an Equal Weight rating.<\/p>\n

Freeport-McMoRan (FCX) \u2014 Scotiabank raised its price target to $77 from $67 and maintained a Sector Outperform rating.<\/p>\n

Full Truck Alliance (YMM) \u2014 Nomura set an $11 price target on Full Truck Alliance.<\/p>\n

Globus Maritime (GLBS) \u2014 Maxim Group raised its price target to $5 from $3 and maintained a Buy rating.<\/p>\n

Globus Medical (GMED) \u2014 Piper Sandler lowered its price target to $100 from $115 while maintaining an Overweight rating.<\/p>\n

Grupo Mexico (GMBXF) \u2014 Scotiabank reiterated a Sector Perform rating.<\/p>\n

Haemonetics (HAE) \u2014 Mizuho raised its price target to $85 from $70 and maintained an Outperform rating.<\/p>\n

Halma (HLMAF) \u2014 BNP Paribas Exane upgraded Halma to Outperform.<\/p>\n

Harley-Davidson (HOG) \u2014 Wolfe Research reiterated an Outperform rating on Harley-Davidson.<\/p>\n

Harmonic (HLIT) \u2014 Rosenblatt reiterated a Buy rating with a $20 price target.<\/p>\n

HawkEye 360 (HAWK) \u2014 Jefferies upgraded HawkEye 360 to Buy from Hold with a $34 price target.<\/p>\n

Healthpeak Properties (DOC) \u2014 BMO Capital Markets raised its price target to $24 from $20 and maintained an Outperform rating.<\/p>\n

Hilton Worldwide (HLT) \u2014 Argus raised its price target to $400 from $380 and maintained a Buy rating.<\/p>\n

Hinge Health (HNGE) \u2014 Canaccord raised its price target to $76 from $65, and Raymond James raised its target to $80 from $70, both maintaining positive ratings.<\/p>\n

Hudson Pacific Properties (HPP) \u2014 BMO raised its price target to $16 from $8 and maintained a Market Perform rating.<\/p>\n

Humana (HUM) \u2014 UBS reiterated a Neutral rating on Humana.<\/p>\n

Huntington Bancshares (HBAN) \u2014 Stephens initiated coverage with an Equal Weight rating and a $19 price target.<\/p>\n

ICU Medical (ICUI) \u2014 BTIG initiated coverage with a Buy rating and a $170 price target, while Bernstein downgraded the stock to Market Perform.<\/p>\n

Incyte (INCY) \u2014 BMO reiterated an Underperform rating on Incyte.<\/p>\n

Innodata (INOD) \u2014 BWS Financial reiterated a Buy rating, raised its price target to $140 from $110, and named it a Top Pick.<\/p>\n

Inspire Medical Systems (INSP) \u2014 Royal Bank of Canada downgraded the stock to Buy from Sector Perform.<\/p>\n

Inspire Medical Systems (INSP) \u2014 Oppenheimer reiterated a Market Perform rating.<\/p>\n

Intellia Therapeutics (NTLA) \u2014 Citizens JMP reiterated a Outperform rating with a $30 price target.<\/p>\n

Intellia Therapeutics (NTLA) \u2014 Wedbush reiterated a Neutral rating with a $12 price target.<\/p>\n

Intellia Therapeutics (NTLA) \u2014 Citigroup reiterated a Outperform rating (no price target provided).<\/p>\n

Intellia Therapeutics (NTLA) \u2014 HC Wainwright reiterated a Buy rating with a $25 price target.<\/p>\n

Intellia Therapeutics (NTLA) \u2014 New Street Research set a $25 price target.<\/p>\n

Intercorp Financial Services (IFS) \u2014 JPMorgan downgraded the stock to Neutral from Overweight with a $56 price target.<\/p>\n

Invitation Homes (INVH) \u2014 BMO raised its price target to $35 from $32 and maintained a Market Perform rating.<\/p>\n

Invivyd (IVVD) \u2014 HC Wainwright reiterated a Buy rating with a $10 price target.<\/p>\n

Ionis Pharmaceuticals (IONS) \u2014 TD Cowen reiterated a Buy rating with a $108 price target.<\/p>\n

Ivanhoe Mines (IVN) \u2014 Scotiabank raised its price target to C$13.50 from C$13.00 and maintained a Sector Perform rating.<\/p>\n

Jabil (JBL) \u2014 Stifel raised its price target to $430 from $290 and maintained a Buy rating.<\/p>\n

Jade Biosciences (JBIO) \u2014 UBS initiated coverage with a Buy rating and a $45 price target.<\/p>\n

Jeronimo Martins (JRONY) \u2014 Citigroup reiterated a Buy rating.<\/p>\n

Kalaris Therapeutics (KLRS) \u2014 TD Cowen initiated coverage with a Buy rating.<\/p>\n

KeyCorp (KEY) \u2014 Stephens initiated coverage with an Overweight rating and a $26 price target.<\/p>\n

Kilroy Realty (KRC) \u2014 BMO raised its price target to $38 from $34 and maintained a Market Perform rating.<\/p>\n

Kinder Morgan (KMI) \u2014 UBS reiterated a Buy rating with a $43 price target.<\/p>\n

Knight-Swift Transportation (KNX) \u2014 Citi downgraded the stock to Neutral from Buy and set a $90 price target.<\/p>\n

Knightscope (KSCP) \u2014 Ascendiant Capital Markets lowered its price target to $23 from $26 and maintained a Buy rating.<\/p>\n

Kodiak AI (KDK) \u2014 Craig Hallum initiated coverage with a Buy rating and a $12 price target.<\/p>\n

Kura Oncology (KURA) \u2014 Citizens JMP and Sanford Bernstein both reiterated positive ratings with a $24 price target.<\/p>\n

Lam Research (LRCX) \u2014 Oppenheimer raised its price target to $400 from $330 and maintained an Outperform rating.<\/p>\n

Lennar (LEN) \u2014 BTIG set a price target of $67 with no rating change specified.<\/p>\n

Lennar (LEN) \u2014 Wells Fargo lowered its price target to $85 from $90 and maintained an Equal Weight rating.<\/p>\n

Lennar (LEN) \u2014 Royal Bank of Canada lowered its price target to $85 from $88 and maintained an Underperform rating.<\/p>\n

Lennar (LEN) \u2014 Evercore raised its price target to $87 from $82 but maintained an Underperform rating.<\/p>\n

Lennar (LEN) \u2014 Barclays lowered its price target to $79 from $80 and maintained an Underweight rating.<\/p>\n

Life Time Group (LTH) \u2014 Guggenheim raised its price target to $41 from $36 and maintained a Buy rating.<\/p>\n

Lifeway Foods (LWAY) \u2014 Benchmark reiterated a Buy rating.<\/p>\n

Lundin Mining (LUNMF) \u2014 Scotiabank reiterated an Outperform rating.<\/p>\n

Lyell Immunopharma (LYEL) \u2014 Needham and Citizens JMP both reiterated Buy and Market Outperform ratings with targets between $34 and $44.<\/p>\n

Malibu Boats (MBUU) \u2014 DA Davidson reiterated a Neutral rating with a $30 price target.<\/p>\n

Marathon Petroleum (MPC) \u2014 Wells Fargo reiterated an Overweight rating with a $344 price target.<\/p>\n

Marriott International (MAR) \u2014 UBS raised its price target to $412 from $336, while Bernstein also set a $412 target.<\/p>\n

MGM Resorts (MGM) \u2014 UBS set a $49 price target, while Stifel downgraded the stock to Hold.<\/p>\n

Micron Technology (MU) \u2014 RBC and TD Cowen both significantly raised price targets to $1,200\u2013$1,500 respectively, while maintaining bullish ratings.<\/p>\n

Mirum Pharmaceuticals (MIRM) \u2014 Citizens JMP raised its price target to $146 from $140 and maintained a Market Outperform rating.<\/p>\n

Mirum Pharmaceuticals (MIRM) \u2014 CLSA set a $146 price target with no rating change specified.<\/p>\n

Mirum Pharmaceuticals (MIRM) \u2014 Citi reiterated an Outperform rating.<\/p>\n

Mirum Pharmaceuticals (MIRM) \u2014 HC Wainwright reiterated a Buy rating.<\/p>\n

Mosaic (MOS) \u2014 BNP Paribas Exane lowered its price target to $29 from $30.<\/p>\n

National Health Investors (NHI) \u2014 BMO lowered its price target to $80 from $90 while maintaining an Outperform rating.<\/p>\n

Nexa Resources (NEXA) \u2014 Scotiabank slightly raised its price target to $14.50 from $14.<\/p>\n

Northern Oil and Gas (NOG) \u2014 Raymond James lowered its price target to $30 from $35.<\/p>\n

Northrop Grumman (NOC) \u2014 Raymond James reiterated an Outperform rating.<\/p>\n

Nurix Therapeutics (NRIX) \u2014 Needham reiterated a Buy rating with a $34 price target.<\/p>\n

Old Dominion Freight Line (ODFL) \u2014 Citi downgraded the stock to Sell.<\/p>\n

Ollie\u2019s Bargain Outlet (OLLI) \u2014 KeyCorp reiterated an Overweight rating.<\/p>\n

Omega Healthcare Investors (OHI) \u2014 Citi reiterated a Market Perform rating.<\/p>\n

Onsemi (ON) \u2014 Citi raised its price target to $120 from $100.<\/p>\n

Opus Genetics (IRD) \u2014 Citizens JMP reiterated a Market Outperform rating with an $11 price target.<\/p>\n

OrthoPediatrics (KIDS) \u2014 TD Cowen reiterated a Buy rating.<\/p>\n

Paychex (PAYX) \u2014 Citi upgraded the stock to Buy and raised its price target to $140 from $99.<\/p>\n

Payoneer Global (PAYO) \u2014 Needham downgraded the stock to Hold.<\/p>\n

Peloton (PTON) \u2014 UBS reiterated a Buy rating.<\/p>\n

Phillips 66 (PSX) \u2014 UBS reiterated a Buy rating with a $212 price target.<\/p>\n

Piedmont Realty Trust (PDM) \u2014 Truist reiterated a Buy rating.<\/p>\n

Pinterest (PINS) \u2014 Guggenheim reiterated a Buy rating.<\/p>\n

Planet Labs PBC (PL) \u2014 Deutsche Bank reiterated a Buy rating with a $36 price target.<\/p>\n

PNC Financial (PNC) \u2014 Stephens initiated coverage with an Overweight rating and a $265 price target.<\/p>\n

PPG Industries (PPG) \u2014 BMO raised its price target to $140 from $135 and maintained an Outperform rating.<\/p>\n

Primoris Services (PRIM) \u2014 Wolfe Research reiterated an Outperform rating with a $149 price target.<\/p>\n

Public Storage (PSA) \u2014 BMO raised its price target to $340 from $305.<\/p>\n

Quantum Computing Inc. (QUBT) \u2014 Ascendiant raised its price target to $30 from $27 and maintained a Buy rating.<\/p>\n

Regions Financial (RF) \u2014 Stephens initiated coverage with an Equal Weight rating.<\/p>\n

ResMed (RMD) \u2014 Citi lowered its price target to $270 and maintained a Buy rating.<\/p>\n

Rezolute (RZLT) \u2014 Guggenheim raised its price target to $11 from $6 and maintained a Buy rating.<\/p>\n

RH (RH) \u2014 Citi raised its price target to $166 from $150 and maintained a Neutral rating.<\/p>\n

Rhythm Pharmaceuticals (RYTM) \u2014 Wells Fargo raised its price target to $155 from $144 and maintained an Overweight rating.<\/p>\n

Rivian Automotive (RIVN) \u2014 Cantor Fitzgerald reiterated a Neutral rating.<\/p>\n

Rocket Lab (RKLB) \u2014 KeyCorp upgraded the stock to Overweight with a $135 price target.<\/p>\n

Rogers Corp (ROG) \u2014 B. Riley raised its price target to $200 from $155 and maintained a Buy rating.<\/p>\n

Roku (ROKU) \u2014 Citizens JMP raised its price target to $175 from $170 and maintained a Market Outperform rating.<\/p>\n

Roku (ROKU) \u2014 Needham raised its price target to $170 from $140 and maintained a Buy rating.<\/p>\n

Roku (ROKU) \u2014 Citi reiterated an Outperform rating.<\/p>\n

Roku (ROKU) \u2014 Robert W. Baird downgraded Roku to Neutral from Outperform and set a $160 price target.<\/p>\n

Roku (ROKU) \u2014 William Blair downgraded Roku to Market Perform from Outperform.<\/p>\n

Roku (ROKU) \u2014 Oppenheimer downgraded Roku to Market Perform from Outperform.<\/p>\n

Roku (ROKU) \u2014 Jefferies downgraded Roku to Hold from Buy and set a $160 price target.<\/p>\n

Roku (ROKU) \u2014 KeyCorp downgraded Roku to Sector Weight from Overweight.<\/p>\n

Runway Growth Finance (RWAY) \u2014 BofA downgraded the stock to Underperform.<\/p>\n

SAB Biotherapeutics (SABS) \u2014 HC Wainwright reiterated a Buy rating with a $10 price target, while Leerink raised its target to $12.<\/p>\n

Safestore (SFSHF) \u2014 Morgan Stanley maintained an Underweight rating.<\/p>\n

Saia (SAIA) \u2014 Citi downgraded the stock to Neutral.<\/p>\n

Salesforce (CRM) \u2014 Wolfe Research reiterated an Outperform rating.<\/p>\n

Sasol (SSL) \u2014 JPMorgan downgraded the stock to Neutral.<\/p>\n

Satellogic (SATL) \u2014 Cantor Fitzgerald reiterated an Overweight rating.<\/p>\n

Seagate Technology (STX) \u2014 Morgan Stanley raised its price target to $1,035 from $767 and maintained an Overweight rating.<\/p>\n

ServiceNow (NOW) \u2014 Cantor Fitzgerald and Benchmark both maintained positive outlooks with $130 price targets.<\/p>\n

Silvercorp Metals (SVM) \u2014 Roth MKM and Jefferies both upgraded the stock to Buy.<\/p>\n

SoftwareOne (SWONF) \u2014 BNP Paribas upgraded the stock to Outperform.<\/p>\n

Sonos (SONO) \u2014 Rosenblatt reiterated a Buy rating with a $21 price target.<\/p>\n

SOPHiA GENETICS (SOPH) \u2014 BTIG reiterated a Buy rating with an $8 price target.<\/p>\n

Southern Copper (SCCO) \u2014 Scotiabank maintained an Underperform stance but slightly raised its price target to $140.<\/p>\n

Strategy Inc (MSTR) \u2014 Cantor Fitzgerald reiterated an Overweight rating.<\/p>\n

Stride (LRN) \u2014 BMO maintained a Market Perform rating.<\/p>\n

Strive (ASST) \u2014 Benchmark reiterated a Buy rating.<\/p>\n

Take-Two Interactive (TTWO) \u2014 DA Davidson reiterated a Buy rating with a $300 price target.<\/p>\n

Tanger (SKT) \u2014 BMO raised its price target to $42 from $40 and maintained a Market Perform rating.<\/p>\n

Target (TGT) \u2014 Bernstein reiterated a Market Perform rating.<\/p>\n

TE Connectivity (TEL) \u2014 Barclays raised its price target to $300 and maintained an Overweight rating.<\/p>\n

Teck Resources (TECK) \u2014 Scotiabank maintained a Sector Perform rating.<\/p>\n

TeraWulf (WULF) \u2014 Bank of America initiated coverage with a Buy rating and a $34 price target.<\/p>\n

Tesla (TSLA) \u2014 HSBC maintained a Hold rating.<\/p>\n

Texas Instruments (TXN) \u2014 Citi raised its price target to $345 and maintained a Buy rating.<\/p>\n

TFI International (TFII) \u2014 Citi raised its price target to $188 and maintained a Buy rating.<\/p>\n

Thor Industries (THO) \u2014 DA Davidson maintained a Neutral rating with an $80 price target.<\/p>\n

TransDigm (TDG) \u2014 JPMorgan raised its price target to $1,450 and maintained a Neutral rating.<\/p>\n

Travere Therapeutics (TVTX) \u2014 Citi raised its price target to $70 and maintained a Buy rating.<\/p>\n

TripAdvisor (TRIP) \u2014 DA Davidson maintained a Neutral rating, while BTIG maintained a Buy rating.<\/p>\n

Truist Financial (TFC) \u2014 Stephens initiated coverage with an Overweight rating and a $59 price target.<\/p>\n

Twist Bioscience (TWST) \u2014 TD Cowen raised its price target to $89 from $68 and maintained a Buy rating.<\/p>\n

Twist Bioscience (TWST) \u2014 UBS set a price target of $89 with no rating change specified.<\/p>\n

Twist Bioscience (TWST) \u2014 Canaccord Genuity initiated coverage with a Buy rating and a $90 price target.<\/p>\n

U.S. Bancorp (USB) \u2014 Stephens initiated coverage with an Equal Weight rating.<\/p>\n

United Community Banks (UCB) \u2014 DA Davidson raised its price target to $40 and maintained a Buy rating.<\/p>\n

United Parks & Resorts (PRKS) \u2014 UBS maintained a Neutral rating.<\/p>\n

Upstart (UPST) \u2014 Needham reiterated a Buy rating with a $37 price target.<\/p>\n

Vale (VALE) \u2014 Scotiabank and RBC maintained neutral\/sector perform ratings.<\/p>\n

VEON (VEON) \u2014 Benchmark reiterated a Buy rating.<\/p>\n

Vornado Realty Trust (VNO) \u2014 BMO raised its price target to $43 and maintained an Outperform rating.<\/p>\n

Welltower (WELL) \u2014 RBC reiterated an Outperform rating with a $238 price target.<\/p>\n

Western Digital (WDC) \u2014 Morgan Stanley raised its price target to $650 and maintained an Overweight rating.<\/p>\n

Winnebago Industries (WGO) \u2014 DA Davidson maintained a Neutral rating.<\/p>\n

Wix.com (WIX) \u2014 Needham maintained a Buy rating with an $80 price target.<\/p>\n

XPO (XPO) \u2014 Citi raised its price target to $236 and maintained a Neutral rating.<\/p>\n

Zions Bancorporation (ZION) \u2014 Stephens initiated coverage with an Overweight rating and a $79 price target.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) Today\u2019s analyst ratings show a mixed but still broadly constructive market tone, with increasing dispersion in conviction.\u00a0 Analysts continue to support long-term…<\/p>\n","protected":false},"author":3,"featured_media":55651,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-73937","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"\nAmerican Analyst Updates: June 15th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Updates: June 15th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Today\u2019s analyst ratings show a mixed but still broadly constructive market tone, with increasing dispersion in conviction.\u00a0 Analysts continue to support long-term...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-15T21:29:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-15T21:34:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/10\/Tesla-auto.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"17 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Updates: June 15th, 2026\",\"datePublished\":\"2026-06-15T21:29:18+00:00\",\"dateModified\":\"2026-06-15T21:34:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/\"},\"wordCount\":3421,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/\",\"name\":\"American Analyst Updates: June 15th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-06-15T21:29:18+00:00\",\"dateModified\":\"2026-06-15T21:34:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Updates: June 15th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Updates: June 15th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Updates: June 15th, 2026","og_description":"Analyst Ratings (USA) Today\u2019s analyst ratings show a mixed but still broadly constructive market tone, with increasing dispersion in conviction.\u00a0 Analysts continue to support long-term...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-06-15T21:29:18+00:00","article_modified_time":"2026-06-15T21:34:45+00:00","og_image":[{"width":1200,"height":720,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/10\/Tesla-auto.webp","type":"image\/webp"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"17 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Updates: June 15th, 2026","datePublished":"2026-06-15T21:29:18+00:00","dateModified":"2026-06-15T21:34:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/"},"wordCount":3421,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/","name":"American Analyst Updates: June 15th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-06-15T21:29:18+00:00","dateModified":"2026-06-15T21:34:45+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-june-15th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Updates: June 15th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/73937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=73937"}],"version-history":[{"count":13,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/73937\/revisions"}],"predecessor-version":[{"id":73952,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/73937\/revisions\/73952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/55651"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=73937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=73937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=73937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}